最近和预期的新药批准 (2024年第三季度至2025年第二季度)
Matthew H Rim1, Collin Dean1, Enela Aliaj1
1Northwestern Medicine, Chicago, IL, USA.
概括
药剂师可以为新的药物批准做好准备,包括新的癌症和罕见疾病疗法,预计在2024年第三季度和2025年第二季度之间. 本综述强调了影响医院和诊所护理的关键药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 罕见疾病 罕见疾病
背景情况:
- 医疗系统药剂师对于管理药物配方和临床计划至关重要.
- 监控制药管道对于资源配置和优化使用新疗法来治疗患者至关重要.
研究的目的:
- 为药剂师提供预计在未来12个月内获得新药批准的概述.
- 支持用于表单管理,资源分配和临床程序开发的战略规划.
主要方法:
- 审查等待美国食品和药物管理局 (FDA) 批准的新药.
- 分析的重点是预计在医疗保健环境中具有重大临床和财务影响的药物.
- 在54种预期获得批准的新药中进行选择.
主要成果:
- 预期的批准包括新的细胞疗法和针对各种癌症 (胆道,胃,胰腺,乳腺) 的向药物.
- 几种静脉注射药物将具有皮下配方,从而增强了给药选择.
- 管道包括针对罕见疾病的新型治疗方法,如遗传性血管,黄斑端膜瘤,先天性上腺增生和巴斯综合征.
- 具体预期的药物包括对血友病,亚托皮炎的治疗,以及第一个口服penem抗生素.
结论:
- 药物管道继续得到加强,用于癌症和罕见疾病的新疗法.
- 药剂师应该了解这些即将批准的信息,以确保有效地融入患者护理和卫生系统运营.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
476
07:49Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
11.5K
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
